Adelis Equity Partners Becomes Majority Owner of Nordic BioSite Group
May 28, 2021
Adelis Equity Partners has acquired a majority stake in Nordic BioSite Group to accelerate the group's growth and pan‑European expansion of its life‑science research and diagnostics distribution platform. Tellacq Partners, together with the founders and management team, had built the group (including Nordic Biosite AB, Sanbio BV and Biomol GmbH); the parties did not disclose the purchase price.
- Buyers
- Adelis Equity Partners
- Targets
- Nordic BioSite Group
- Sellers
- Tellacq Partners, Founders, Management team
- Industry
- Healthcare Services
- Location
- Sweden
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.